MROC: A study looking at using mpMRI scans in ovarian cancer

Trial at a glance

Closed trial

  • Cancer type: Epithelial – clear-cell | Epithelial – mucinous | Epithelial – low-grade serous | Rarer ovarian tumours | Suspected ovarian cancer
  • Treatment stage: Prevention or diagnosis
  • Acronym: MROC

MROC: A study looking at using mpMRI scans in staging and treatment decisions for ovarian cancer

Who can take part

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.


You may be able to take part in this clinical trial if you:

  • suspected ovarian cancer
  • a diagnosis of ovarian cancer but have not yet had surgery

This is not an exhaustive list. If you're interested in participating in a clinical trial, you should speak to your doctor about what other criteria might apply.

About the trial

Surgery is the usual treatment for ovarian cancer. A CT scan is used to check where the cancer is in the body and helps doctors to know if surgery would be a suitable treatment choice. However, sometimes the CT scan can’t:

  • tell the difference between disease that isn't cancer (benign) and cancer (malignant disease)
  • always show how far the cancer has spread (the stage of the cancer)
  • show when it's best to have an operation

This means that some women have surgery and don’t need it because they don’t have cancer. Some women go for an operation and are then unable to have the cancer removed because it's spread too far.

A mpMRI scan is very similar to a MRI scan but can give doctors extra information about the person's disease. Doctors want to see if:

  • a mpMRI scan is more effective than a CT scan at showing who needs an operation and how big the operation should be
  • a mpMRI should either replace or be used as well as a CT scan

If you take part in this study, you'll need to:

  • have a CT scan (the normal test).
  • have a mpMRI scan (the test being investigated).